Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 01, 2020

BUY
$41.72 - $87.2 $158,536 - $331,360
3,800 Added 68.94%
9,312 $476,000
Q3 2018

Oct 29, 2018

BUY
$38.0 - $51.1 $125,096 - $168,221
3,292 Added 148.29%
5,512 $209,000
Q4 2017

Feb 02, 2018

BUY
$29.7 - $45.7 $65,934 - $101,454
2,220
2,220 $87,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.